美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=BLA761074"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
83257-001-11 83257-001 HUMAN PRESCRIPTION DRUG OGIVRI trastuzumab-dkst INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20231001 N/A BLA BLA761074 Biocon Biologics Inc. TRASTUZUMAB 150 mg/7.4mL 1 VIAL in 1 CARTON (83257-001-11) / 15 mL in 1 VIAL
67457-991-15 67457-991 HUMAN PRESCRIPTION DRUG OGIVRI trastuzumab INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20191129 20270228 BLA BLA761074 Mylan Institutional LLC TRASTUZUMAB 150 mg/7.4mL 1 VIAL in 1 CARTON (67457-991-15) / 15 mL in 1 VIAL
67457-847-44 67457-847 HUMAN PRESCRIPTION DRUG OGIVRI trastuzumab KIT 20191129 20270430 BLA BLA761074 Mylan Institutional LLC 1 KIT in 1 CARTON (67457-847-44) * 20 mL in 1 VIAL, MULTI-DOSE (67457-845-50) * 20 mL in 1 VIAL (67457-846-20)
83257-004-12 83257-004 HUMAN PRESCRIPTION DRUG OGIVRI trastuzumab-dkst KIT 20231001 N/A BLA BLA761074 Biocon Biologics Inc. 1 KIT in 1 CARTON (83257-004-12) * 20 mL in 1 VIAL, MULTI-DOSE (83257-003-11) * 20 mL in 1 VIAL (83257-002-11)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase